Literature DB >> 14691058

Topiramate hyperpolarizes and modulates the slow poststimulus AHP of rat olfactory cortical neurones in vitro.

Emilio Russo1, Andrew Constanti.   

Abstract

1. The effects of the novel antiepileptic drug topiramate (TPM) were investigated in rat olfactory cortex neurones in vitro using a current/voltage clamp technique. 2. In 80% of recorded cells, bath application of TPM (20 microm) reversibly hyperpolarized and inhibited neuronal repetitive firing by inducing a slow outward membrane current, accompanied by a conductance increase. The response was reproducible after washout, and was most likely carried largely by K(+) ions, although other ionic conductances may also have contributed. 3. In 90% of cells, TPM (20 microm) also enhanced and prolonged the slow (Ca(2+)-dependent) poststimulus afterhyperpolarization (sAHP) and underlying slow outward tail current (sI(AHP)). This effect was due to a selective enhancement/prolongation of an underlying L-type Ca(2+) current that was blocked by nifedipine (20 microm); the TPM response was unlikely to involve an interaction at PKA-dependent phosphorylation sites. 4. The carbonic anhydrase (CA) inhibitor acetazolamide (ACTZ, 20 microm) and the poorly membrane permeant inhibitor benzolamide (BZ, 50 microm) both mimicked the membrane effects of TPM, in generating a slow hyperpolarization (slow outward current under voltage clamp) and sAHP enhancement. ACTZ and BZ occluded the effects of TPM in generating the outward current response, but were additive in producing the sAHP modulatory effect, suggesting different underlying response mechanisms. 5. In bicarbonate/CO(2)-free, HEPES-buffered medium, all the membrane effects of TPM and ACTZ were reproducible, therefore not dependent on CA inhibition. 6. We propose that both novel effects of TPM and ACTZ exerted on cortical neurones may contribute towards their clinical effectiveness as anticonvulsants.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14691058      PMCID: PMC1574203          DOI: 10.1038/sj.bjp.0705617

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  97 in total

Review 1.  [New prospects in the treatment of migraine].

Authors:  J Pascual
Journal:  Neurologia       Date:  1999-12       Impact factor: 3.109

2.  Effects of topiramate on sustained repetitive firing and spontaneous recurrent seizure discharges in cultured hippocampal neurons.

Authors:  R J DeLorenzo; S Sombati; D A Coulter
Journal:  Epilepsia       Date:  2000       Impact factor: 5.864

3.  Novel action of BAPTA series chelators on intrinsic K+ currents in rat hippocampal neurones.

Authors:  B Lancaster; A M Batchelor
Journal:  J Physiol       Date:  2000-01-15       Impact factor: 5.182

4.  Sodium bromide: effects on different patterns of epileptiform activity, extracellular pH changes and GABAergic inhibition.

Authors:  H Meierkord; F Grünig; U Gutschmidt; R Gutierrez; M Pfeiffer; A Draguhn; C Brückner; U Heinemann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2000-01       Impact factor: 3.000

5.  Contribution of L-type calcium channels to epileptiform activity in hippocampal and neocortical slices of guinea-pigs.

Authors:  H Straub; R Köhling; A Frieler; M Grigat; E J Speckmann
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

6.  Pharmacological identification of the K(+) currents mediating the hypoglycemic hyperpolarization of rat midbrain dopaminergic neurones.

Authors:  S Marinelli; G Bernardi; P Giacomini; N B Mercuri
Journal:  Neuropharmacology       Date:  2000-04-03       Impact factor: 5.250

7.  Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons.

Authors:  J W Gibbs; S Sombati; R J DeLorenzo; D A Coulter
Journal:  Epilepsia       Date:  2000       Impact factor: 5.864

8.  Topiramate as an inhibitor of carbonic anhydrase isoenzymes.

Authors:  S J Dodgson; R P Shank; B E Maryanoff
Journal:  Epilepsia       Date:  2000       Impact factor: 5.864

9.  Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism.

Authors:  H S White; S D Brown; J H Woodhead; G A Skeen; H H Wolf
Journal:  Epilepsia       Date:  2000       Impact factor: 5.864

Review 10.  An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action.

Authors:  R P Shank; J F Gardocki; A J Streeter; B E Maryanoff
Journal:  Epilepsia       Date:  2000       Impact factor: 5.864

View more
  6 in total

1.  Topiramate does not alter expression in rat brain of enzymes of arachidonic acid metabolism.

Authors:  Sandra Ghelardoni; Richard P Bazinet; Stanley I Rapoport; Francesca Bosetti
Journal:  Psychopharmacology (Berl)       Date:  2005-02-18       Impact factor: 4.530

Review 2.  Molecular targets for antiepileptic drug development.

Authors:  Brian S Meldrum; Michael A Rogawski
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

3.  Topiramate modulates pH of hippocampal CA3 neurons by combined effects on carbonic anhydrase and Cl-/HCO3- exchange.

Authors:  Tobias Leniger; Jan Thöne; Martin Wiemann
Journal:  Br J Pharmacol       Date:  2004-06-14       Impact factor: 8.739

4.  Investigation of the effects of the novel anticonvulsant compound carisbamate (RWJ-333369) on rat piriform cortical neurones in vitro.

Authors:  B J Whalley; G J Stephens; A Constanti
Journal:  Br J Pharmacol       Date:  2009-03       Impact factor: 8.739

Review 5.  Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.

Authors:  Richard P Shank; Bruce E Maryanoff
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

Review 6.  New generation anticonvulsants for the treatment of epilepsy in children.

Authors:  Elizabeth J Donner; O Carter Snead
Journal:  NeuroRx       Date:  2006-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.